Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer
Clinical trial NCT01547299 · COMPLETED
Trial details
- NCT number
- NCT01547299
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-31
- Primary completion
- 2013-11-30
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.